ZILLOW GROUP, INC.
For the period ended Sep 30, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 4, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Share-Based Awards
Note 9. Share-Based Awards
In connection with the annual review cycle, option awards and restricted stock units are granted under the Zillow Group, Inc. 2020 Incentive Plan (the “2020 Plan”) during the first quarter of each year and typically vest quarterly over four years. On August 20, 2026, pursuant to delegated authority under the 2020 Plan, a supplemental grant of either option awards or restricted stock units, depending on employee position, was authorized and granted to eligible employees. Directors and officers then subject to Section 16 of the Exchange Act were excluded from this supplemental grant. The supplemental option awards and restricted stock units vest quarterly over a two-year period from the grant date, with the first vesting date in November 2026. The exercisability and settlement terms of these equity awards are otherwise consistent with the terms of the option awards and restricted stock units typically granted under the 2020 Plan. For additional information regarding our share-based awards, see Note 11 in the Notes to the Consolidated Financial Statements in Part II, Item 8 in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
Option Awards
The following table summarizes option award activity for the nine months ended September 30, 2026:
| Numberof SharesSubject toExistingOptions (in thousands) | Weighted-AverageExercisePrice PerShare | Weighted-AverageRemainingContractualLife (in years) | AggregateIntrinsicValue(in millions) | |
|---|---|---|---|---|
| Outstanding at January 1, 2026 | 27,303 | $49.79 | 5.7 | $565 |
| Granted | 5,580 | 41.94 | ||
| Exercised | (811) | 28.93 | ||
| Forfeited or canceled | (991) | 52.95 | ||
| Outstanding at September 30, 2026 | 31,081 | 48.82 | 5.7 | — |
| Vested and exercisable at September 30, 2026 | 23,527 | 48.54 | 4.6 | — |
The following assumptions were used to determine the fair value of option awards granted for the periods presented:
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Expected volatility | 53% | 54% | 53% - 56% | 54% - 60% |
| Risk-free interest rate | 4.70% | 3.82% | 3.87% - 4.70% | 3.82% - 4.17% |
| Weighted-average expected life | 5.8 years | 5.3 years | 5.8 - 7.0 years | 5.3 - 6.8 years |
| Weighted-average fair value of options granted | $18.90 | $46.43 | $22.69 | $43.34 |
As of September 30, 2026, there was a total of $194 million in unrecognized compensation cost related to unvested option awards.
Restricted Stock Units
The following table summarizes activity for restricted stock units for the nine months ended September 30, 2026:
| RestrictedStock Units (in thousands) | Weighted-Average Grant Date Fair Value | |
|---|---|---|
| Unvested outstanding at January 1, 2026 | 9,319 | $61.83 |
| Granted | 9,314 | 40.41 |
| Vested | (4,000) | 53.46 |
| Forfeited | (1,655) | 56.68 |
| Unvested outstanding at September 30, 2026 | 12,978 | $49.70 |
As of September 30, 2026, there was a total of $603 million in unrecognized compensation cost related to unvested restricted stock units.
Share-Based Compensation Expense
The following table presents the effects of share-based compensation expense in our condensed consolidated statements of operations during the periods presented (in millions):
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Cost of revenue | $2 | $3 | $6 | $9 |
| Sales and marketing | 13 | 18 | 43 | 55 |
| Technology and development | 33 | 41 | 97 | 119 |
| General and administrative | 26 | 37 | 84 | 112 |
| Impairment and restructuring costs | 12 | — | 25 | — |
| Total share-based compensation | $86 | $99 | $255 | $295 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.